This Canadian Health and Wellness Stock Is Riding Serious Tailwinds That Could Send Shares Soaring

Jamieson Wellness Inc. (TSX:JWEL) is an underrated business with a solid growth strategy and a tonne of catalysts. Here’s why investors would be wise to pick up shares today.

| More on:
The Motley Fool

As the cold and flu season comes around the corner, it’s expected that many Canadians will be taking supplements to beef up their immune systems to combat the nasty bugs that are ready to be unleashed. Nobody wants a cold or the flu, but we all know if a family member gets it, then we’re likely next.

Fortunately, there is a way to profit from one of the grossest times of the year!

Jamieson Wellness Inc. (TSX:JWEL) is a vitamin, mineral, and health supplement manufacturer that has been in business for nearly a century. It’s the go-to brand when it comes to supplements, as many Canadians gravitate towards Jamieson’s green-cap bottle when they’re at the health and wellness section of the grocery store. Jamieson is a trusted brand that’s loved not just by Canadians, but in various international markets as well.

The company recently had its IPO earlier this year. Although I’m not a fan of investing in stocks that haven’t been public for at least three years, I think Jamieson is a worthy exception because of the fairly predictable nature of the business in addition to many medium- to long-term catalysts that could send the stock flying to much higher levels.

Jamieson’s new cold and flu product could send sales flying

Back to the cold and flu season. It’s like the next market correction: everyone dreads it, but it’s coming whether you’re ready or not. Jamieson Wellness is releasing a new cold and flu product called “Cold Fighter” to help Canadians prepare for the upcoming sick season.

Do you feel like you’re starting to come down with something? The Cold Fighter chewable is marketed to fight early signs of cold and flu symptoms in addition to relieving cold symptoms if you’ve already got the full-blown cold. Taking the chewable once per day is also marketed to reduce the duration of colds.

I don’t know about you, but this product sounds like a must-have for every medicine cabinet out there. I think the product will be one of Jamieson’s top sellers for the fall season, and that could mean a nice bump to the company’s third-quarter numbers.

Baby boomers are getting older and need more supplements

Another gradual long-term tailwind lies in the baby boomer generation, which is expected to be a gigantic consumer of vitamins, minerals, and other supplements. The Canadian vitamin industry was worth ~$431 million last year and going forward, it’s expected that it’ll be worth even more as baby boomers continue to age. Jamieson has a dominant position in the Canadian vitamin market, but there’s still a lot of room to run, and as the company releases new products like Cold Fighter chewables, I believe the company is setting itself up to be a behemoth which could control more than half of the Canadian vitamin market in a few years (Jamieson controls about a quarter of this market today).

Bottom line

Jamieson is a wonderful business with a respected brand, a promising growth profile, and several tailwinds to be excited about. Although the stock is just a few months off its IPO, I think investors would be wise to accumulate a position gradually over time to get some skin in the game.

Stay smart. Stay hungry. Stay Foolish.

Fool contributor Joey Frenette has no position in any stocks mentioned.  

More on Investing

a person watches stock market trades
Dividend Stocks

Forget Dollarama! 1 Cheaper Canadian Retail Stock With More Growth Potential

With Dollarama trading near its highs, this cheaper Canadian retail stock could be the smarter long-term buy right now.

Read more »

warehouse worker takes inventory in storage room
Tech Stocks

Outlook for Shopify Stock in 2026

Shopify has delivered another strong year, but the bigger question now is whether its expanding platform and AI push can…

Read more »

Dividend Stocks

2 Easy Ways to Boost Your Income (Including Buying Telus Stock)

Telus (TSX:T) and another timely dividend play that's worth checking out for a yield boost!

Read more »

Electricity transmission towers with orange glowing wires against night sky
Dividend Stocks

Passive Income: Is Fortis Stock Still a Buy for its Dividend?

Fortis’s streak or Emera’s yield? Here’s the simple trade-off for TFSA income seekers in 2026.

Read more »

data analyze research
Bank Stocks

Invest $1,000 Per Month to Create $130 in Passive Income in 2026

Consider a closer look at this blue-chip TSX stock if you’re looking to invest $1,000 per month for reliable long-term…

Read more »

Child measures his height on wall. He is growing taller.
Retirement

Here’s the Max Amount Canadians Could Have in a TFSA in 2026

Confused about your TFSA contribution limit? Here's how the math works out.

Read more »

AI concept person in profile
Tech Stocks

TFSA Wealth Plan: Create $1 Million With a Single Canadian Stock

Topicus could help build a $1 million TFSA thanks to sticky software, recurring revenue, and a disciplined acquisition engine if…

Read more »

four people hold happy emoji masks
Dividend Stocks

2 Superbly Simple Canadian Stocks to Buy With $2,000 Right Now

Got $2,000 to invest? Hydro One and Dollarama offer simple, dependable growth and cash flow you don’t need to monitor…

Read more »